Related Experiment Video
Updated: Jul 15, 2026

09:18
Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans
Published on: September 7, 2021
Comparative Phosphoproteomic Analysis Demonstrates That AMPKα2 Knockout Exacerbates Hepatic Aging in Mice
Han Qiao1, Congmin Tang1, Wenzhuo Yu1
1Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Proteomics
|July 14, 2026
Summary
Germline knockout of AMP-activated protein kinase α2 (AMPKα2) worsens liver aging and metabolic dysfunction in mice. This exacerbates glucose-lipid issues and inflammation, revealing new molecular targets for age-related liver disease.
Area of Science:
- Gerontology
- Metabolic Regulation
- Molecular Biology
Background:
- Aging is linked to metabolic dysregulation, particularly in the liver.
- AMP-activated protein kinase α2 (AMPKα2) is crucial for energy metabolism.
- The impact of germline AMPKα2 knockout on aged liver phosphoproteins remains understudied.
Purpose of the Study:
- To investigate the effects of germline AMPKα2 knockout on aged mouse liver.
- To analyze morphological changes, protein phosphorylation, and senescence phenotypes.
- To identify molecular signatures associated with exacerbated hepatic aging.
Main Methods:
- Morphological analysis of liver tissues.
- Western blot (WB) for protein validation and senescence markers.
- Data-independent acquisition (DIA) phosphoproteomics to profile phosphopeptides.
Main Results:
- AMPKα2 knockout exacerbated glucose-lipid metabolism dysfunction, inflammation, and senescence.
- Phosphoproteomics identified 316 differentially modified phosphopeptides, including enhanced phosphorylation of Acaca and HSP90β.
- Reduced phosphorylation of stress response protein HSP27 was observed and validated by WB.
Conclusions:
- AMPKα2 knockout significantly worsens hepatic aging and metabolic dysfunction.
- Novel molecular signatures of AMPKα2 knockout in aged liver were identified.
- HSP27 phosphorylation may be a downstream effect of AMPKα2, offering potential therapeutic targets for age-related liver diseases.
